news – pharmaceutical daily news

Wasdell Group launch serialisation service

The Wasdell Group (Wasdell) has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines.

The National Institute for Health and Care Excellence (NICE) has recommended the use of the EUSA Pharma’s targeted cancer immunotherapy, QARZIBA

Myovant Sciences has completed screening patients for its LIBERTY 1 study, the first of two Phase 3 replicate studies evaluating

Alvogen and Prestige BioPharma have entered into a deal for the exclusive partnership and supply for the commercialization of Prestige

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the Japanese Ministry of Health, Labour and

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Cablivi (caplacizumab) in Europe

Novartis on Friday said it intends to spinoff Alcon, its eye care division, into a separately-traded standalone company, which would

Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the

Novartis and the European Migraine and Headache Alliance (EMHA) Wednesday presented initial findings from the largest global migraine patient study

AstraZeneca and Merck’s Phase III SOLO-1 trial of Lynparza (olaparib) tablets, for women with BRCA-mutated (BRCAm) advanced ovarian cancer treated